const t={rs2736100:{rsid:"rs2736100",gene:"TERT",chromosome:"5",position:1286516,categories:["longevity"],significance:"well-established",riskAllele:"C",normalAllele:"A",trait:"TERT — Telomere Length",riskDescription:"Associated with shorter telomere length and accelerated cellular aging",normalDescription:"Normal telomere maintenance",heterozygousDescription:"Slightly reduced telomere length",populationFrequency:{AA:.25,AC:.5,CC:.25},conditions:["Shorter telomeres","Accelerated aging"],recommendations:["Consider telomere-supportive lifestyle","Regular exercise","Stress management"],references:["PMID:19412176"]},rs12696304:{rsid:"rs12696304",gene:"TERC",chromosome:"3",position:169763483,categories:["longevity"],significance:"well-established",riskAllele:"G",normalAllele:"C",trait:"TERC — Telomerase RNA Component",riskDescription:"Reduced telomerase activity and shorter telomeres",normalDescription:"Normal telomerase RNA expression",heterozygousDescription:"Mildly reduced telomerase activity",populationFrequency:{CC:.35,CG:.47,GG:.18},conditions:["Telomere shortening","Biological aging"],recommendations:["Antioxidant-rich diet","Avoid chronic stress"],references:["PMID:21304973"]},rs10936599:{rsid:"rs10936599",gene:"OBFC1",chromosome:"10",position:105676587,categories:["longevity"],significance:"well-established",riskAllele:"C",normalAllele:"T",trait:"OBFC1 — Telomere Length Regulation",riskDescription:"Associated with shorter leukocyte telomere length",normalDescription:"Normal telomere length regulation",heterozygousDescription:"Modestly shorter telomeres",populationFrequency:{TT:.45,TC:.43,CC:.12},conditions:["Shorter telomeres","Cardiovascular aging"],recommendations:["Maintain healthy BMI","Regular cardiovascular exercise"],references:["PMID:21304973"]},rs7726159:{rsid:"rs7726159",gene:"TERT",chromosome:"5",position:1282414,categories:["longevity"],significance:"well-established",riskAllele:"C",normalAllele:"A",trait:"TERT — Telomere Maintenance",riskDescription:"Variant associated with altered telomere length",normalDescription:"Normal TERT function",heterozygousDescription:"Intermediate telomere effect",populationFrequency:{AA:.3,AC:.48,CC:.22},conditions:["Telomere length variation"],recommendations:["Telomere-supportive nutrients (omega-3, vitamin D)"],references:["PMID:23535729"]},rs2853669:{rsid:"rs2853669",gene:"TERT",chromosome:"5",position:1295234,categories:["longevity"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"TERT Promoter — Telomerase Expression",riskDescription:"Reduced TERT promoter activity and lower telomerase expression",normalDescription:"Normal TERT promoter activity",heterozygousDescription:"Mildly reduced TERT expression",populationFrequency:{GG:.4,GA:.44,AA:.16},conditions:["Reduced telomerase","Accelerated aging risk"],recommendations:["Consider TA-65 or astragalus supplementation discussion with doctor"],references:["PMID:22426483"]},rs2802292:{rsid:"rs2802292",gene:"FOXO3",chromosome:"6",position:108973560,categories:["longevity"],significance:"well-established",riskAllele:"T",normalAllele:"G",trait:"FOXO3 — Longevity Gene",riskDescription:"Common genotype without longevity advantage",normalDescription:"Protective allele associated with exceptional longevity",heterozygousDescription:"Partial longevity benefit",populationFrequency:{TT:.42,TG:.44,GG:.14},conditions:["Longevity","Stress resistance","Insulin sensitivity"],recommendations:["Caloric restriction may amplify FOXO3 benefits","Regular fasting"],references:["PMID:18765803"]},rs429358:{rsid:"rs429358",gene:"APOE",chromosome:"19",position:44908684,categories:["longevity","health"],significance:"well-established",riskAllele:"C",normalAllele:"T",trait:"APOE ε4 — Alzheimer's & Cardiovascular Risk",riskDescription:"APOE ε4 allele: significantly increased risk for late-onset Alzheimer's disease and cardiovascular disease",normalDescription:"APOE ε3 (common variant): average Alzheimer's risk",heterozygousDescription:"One copy of ε4: 3-4x increased Alzheimer's risk",populationFrequency:{TT:.6,TC:.33,CC:.07},conditions:["Late-onset Alzheimer's disease","Cardiovascular disease","Hyperlipidemia"],recommendations:["Regular cognitive assessment after 50","Mediterranean diet","Cardiovascular exercise","DHA supplementation"],references:["PMID:8346443","PMID:19734902"]},rs7412:{rsid:"rs7412",gene:"APOE",chromosome:"19",position:44908822,categories:["longevity","health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"APOE ε2 — Protective Longevity Variant",riskDescription:"APOE ε2 is generally protective; rare homozygosity may affect lipid metabolism",normalDescription:"Standard APOE ε3 allele",heterozygousDescription:"One ε2 copy: reduced Alzheimer's risk",populationFrequency:{CC:.77,CT:.21,TT:.02},conditions:["Reduced Alzheimer's risk (protective)","Type III hyperlipoproteinemia (rare, homozygous)"],recommendations:["Generally protective variant","Monitor lipid panel if homozygous"],references:["PMID:8346443"]},rs5882:{rsid:"rs5882",gene:"CETP",chromosome:"16",position:56995236,categories:["longevity","health"],significance:"well-established",riskAllele:"G",normalAllele:"A",trait:"CETP — HDL Cholesterol & Longevity",riskDescription:"Lower CETP activity, associated with higher HDL and longevity",normalDescription:"Normal CETP activity",heterozygousDescription:"Intermediate HDL levels",populationFrequency:{AA:.4,AG:.45,GG:.15},conditions:["HDL cholesterol levels","Cardiovascular longevity"],recommendations:["Monitor lipid panel","Heart-healthy diet"],references:["PMID:12586883"]},rs1800795:{rsid:"rs1800795",gene:"IL6",chromosome:"7",position:22766645,categories:["longevity","health"],significance:"well-established",riskAllele:"C",normalAllele:"G",trait:"IL-6 — Inflammatory Aging",riskDescription:"Higher IL-6 production, increased systemic inflammation",normalDescription:"Lower baseline inflammation",heterozygousDescription:"Moderate inflammatory response",populationFrequency:{GG:.25,GC:.5,CC:.25},conditions:["Chronic inflammation","Inflammaging","Cardiovascular disease risk"],recommendations:["Anti-inflammatory diet (omega-3, turmeric)","Regular exercise","Adequate sleep"],references:["PMID:9855620"]},rs1042522:{rsid:"rs1042522",gene:"TP53",chromosome:"17",position:7676154,categories:["longevity","health"],significance:"well-established",riskAllele:"C",normalAllele:"G",trait:"TP53 — Tumor Suppressor & Aging",riskDescription:"Pro72 variant: better DNA repair but potentially accelerated aging",normalDescription:"Arg72 variant: enhanced apoptosis",heterozygousDescription:"Heterozygous — balanced repair/apoptosis",populationFrequency:{GG:.4,GC:.45,CC:.15},conditions:["Cancer susceptibility variation","Aging rate"],recommendations:["Regular cancer screening","Antioxidant-rich diet"],references:["PMID:12474143"]},rs3758391:{rsid:"rs3758391",gene:"SIRT1",chromosome:"10",position:69644427,categories:["longevity"],significance:"well-established",riskAllele:"C",normalAllele:"T",trait:"SIRT1 — Sirtuin Longevity Pathway",riskDescription:"Reduced SIRT1 expression affecting cellular stress response",normalDescription:"Normal sirtuin activity supporting longevity",heterozygousDescription:"Intermediate SIRT1 expression",populationFrequency:{TT:.55,TC:.38,CC:.07},conditions:["Cellular aging","Metabolic regulation"],recommendations:["Resveratrol-rich foods","Intermittent fasting","NAD+ precursors (NMN/NR)"],references:["PMID:22882745"]},rs1801282:{rsid:"rs1801282",gene:"PPARG",chromosome:"3",position:12393125,categories:["longevity","health"],significance:"well-established",riskAllele:"C",normalAllele:"G",trait:"PPARγ Pro12Ala — Insulin Sensitivity",riskDescription:"Pro/Pro genotype: higher type 2 diabetes risk",normalDescription:"Ala variant: improved insulin sensitivity",heterozygousDescription:"Intermediate insulin sensitivity",populationFrequency:{CC:.75,CG:.23,GG:.02},conditions:["Type 2 diabetes risk","Insulin resistance"],recommendations:["Regular blood glucose monitoring","Low glycemic diet","Exercise"],references:["PMID:11101840"]},rs1799752:{rsid:"rs1799752",gene:"ACE",chromosome:"17",position:63488529,categories:["longevity","health"],significance:"well-established",riskAllele:"D",normalAllele:"I",trait:"ACE I/D — Cardiovascular & Longevity",riskDescription:"DD genotype: higher ACE levels, cardiovascular risk",normalDescription:"II genotype: endurance advantage, lower ACE",heterozygousDescription:"Intermediate ACE levels",populationFrequency:{II:.25,ID:.5,DD:.25},conditions:["Hypertension risk","Cardiovascular disease","Exercise response"],recommendations:["Blood pressure monitoring","ACE inhibitor response awareness"],references:["PMID:1328889"]},rs2069762:{rsid:"rs2069762",gene:"IL2",chromosome:"4",position:123377980,categories:["longevity"],significance:"moderate",riskAllele:"G",normalAllele:"T",trait:"IL-2 — Immune Function & Longevity",riskDescription:"Altered IL-2 production affecting immune aging",normalDescription:"Normal IL-2 immune signaling",heterozygousDescription:"Intermediate IL-2 levels",populationFrequency:{TT:.45,TG:.42,GG:.13},conditions:["Immune aging","Autoimmune susceptibility"],recommendations:["Support immune health","Adequate zinc and vitamin C"],references:["PMID:16249881"]},rs1800629:{rsid:"rs1800629",gene:"TNF",chromosome:"6",position:31575254,categories:["longevity","health"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"TNF-α — Inflammatory Cytokine",riskDescription:"Higher TNF-α production, increased chronic inflammation",normalDescription:"Normal TNF-α levels",heterozygousDescription:"Mildly elevated TNF-α",populationFrequency:{GG:.7,GA:.27,AA:.03},conditions:["Chronic inflammation","Autoimmune disease risk","Sepsis susceptibility"],recommendations:["Anti-inflammatory lifestyle","Omega-3 fatty acids","Curcumin"],references:["PMID:8833554"]},rs4880:{rsid:"rs4880",gene:"SOD2",chromosome:"6",position:159692840,categories:["longevity"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"SOD2 Ala16Val — Oxidative Stress Defense",riskDescription:"Reduced mitochondrial antioxidant defense",normalDescription:"Efficient mitochondrial superoxide dismutase",heterozygousDescription:"Intermediate antioxidant capacity",populationFrequency:{CC:.25,CT:.5,TT:.25},conditions:["Oxidative stress","Mitochondrial aging","Cancer risk variation"],recommendations:["Antioxidant supplementation (CoQ10, vitamin C)","Avoid excessive iron intake"],references:["PMID:10072423"]},rs1799983:{rsid:"rs1799983",gene:"NOS3",chromosome:"7",position:150999023,categories:["longevity","health"],significance:"well-established",riskAllele:"T",normalAllele:"G",trait:"eNOS — Nitric Oxide & Vascular Health",riskDescription:"Reduced nitric oxide production, impaired vascular function",normalDescription:"Normal endothelial nitric oxide production",heterozygousDescription:"Mildly reduced NO production",populationFrequency:{GG:.42,GT:.44,TT:.14},conditions:["Endothelial dysfunction","Hypertension","Cardiovascular disease"],recommendations:["Beet root juice (nitrates)","L-arginine","Regular exercise"],references:["PMID:9462492"]},rs1800497:{rsid:"rs1800497",gene:"ANKK1/DRD2",chromosome:"11",position:113400106,categories:["longevity","traits"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"DRD2/ANKK1 Taq1A — Dopamine Receptor",riskDescription:"Reduced dopamine D2 receptor density",normalDescription:"Normal dopamine receptor density",heterozygousDescription:"Mildly reduced D2 receptor availability",populationFrequency:{CC:.5,CT:.4,TT:.1},conditions:["Reward sensitivity","Addiction susceptibility","Cognitive function"],recommendations:["Mindfulness practice","Regular dopamine-boosting activities (exercise)"],references:["PMID:2234697"]},rs6265:{rsid:"rs6265",gene:"BDNF",chromosome:"11",position:27679916,categories:["longevity","health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"BDNF Val66Met — Brain-Derived Neurotrophic Factor",riskDescription:"Reduced BDNF secretion, affecting neuroplasticity and memory",normalDescription:"Normal BDNF function supporting brain health",heterozygousDescription:"Mildly reduced activity-dependent BDNF secretion",populationFrequency:{CC:.62,CT:.33,TT:.05},conditions:["Memory and learning variation","Depression susceptibility","Anxiety"],recommendations:["Regular aerobic exercise (boosts BDNF)","Meditation","Lion's mane mushroom"],references:["PMID:14573789"]},rs80357906:{rsid:"rs80357906",gene:"BRCA1",chromosome:"17",position:43093449,categories:["health"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"BRCA1 5382insC — Breast & Ovarian Cancer",riskDescription:"Pathogenic BRCA1 variant: significantly elevated breast and ovarian cancer risk",normalDescription:"No pathogenic BRCA1 variant detected",heterozygousDescription:"Carrier: 60-80% lifetime breast cancer risk",populationFrequency:{CC:.998,CT:.002,TT:0},conditions:["Hereditary breast cancer","Ovarian cancer","Prostate cancer risk"],recommendations:["Genetic counseling strongly recommended","Enhanced screening","Discuss prophylactic options"],references:["PMID:8524414"]},rs28897696:{rsid:"rs28897696",gene:"BRCA2",chromosome:"13",position:32929387,categories:["health"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"BRCA2 — Breast Cancer Susceptibility",riskDescription:"Pathogenic BRCA2 variant associated with increased cancer risk",normalDescription:"No pathogenic BRCA2 variant",heterozygousDescription:"Carrier: elevated breast and pancreatic cancer risk",populationFrequency:{CC:.999,CT:.001,TT:0},conditions:["Hereditary breast cancer","Pancreatic cancer","Male breast cancer"],recommendations:["Genetic counseling","Regular screening","Family cascade testing"],references:["PMID:20104584"]},rs1333049:{rsid:"rs1333049",gene:"9p21.3",chromosome:"9",position:22125503,categories:["health"],significance:"well-established",riskAllele:"C",normalAllele:"G",trait:"9p21 — Coronary Artery Disease",riskDescription:"Significantly increased risk of coronary artery disease and myocardial infarction",normalDescription:"Average cardiovascular risk at this locus",heterozygousDescription:"Moderately increased CAD risk (~1.3x)",populationFrequency:{GG:.25,GC:.5,CC:.25},conditions:["Coronary artery disease","Myocardial infarction","Atherosclerosis"],recommendations:["Regular cardiovascular screening","Lipid panel monitoring","Heart-healthy diet"],references:["PMID:17478679"]},rs10757278:{rsid:"rs10757278",gene:"9p21.3",chromosome:"9",position:22124477,categories:["health"],significance:"well-established",riskAllele:"G",normalAllele:"A",trait:"9p21 — Coronary Heart Disease",riskDescription:"Increased risk of coronary heart disease",normalDescription:"Lower cardiovascular risk at this locus",heterozygousDescription:"Intermediate cardiovascular risk",populationFrequency:{AA:.28,AG:.49,GG:.23},conditions:["Coronary artery disease","Aortic aneurysm"],recommendations:["Cardiovascular risk management","Regular exercise"],references:["PMID:17478681"]},rs4977574:{rsid:"rs4977574",gene:"CDKN2B-AS1",chromosome:"9",position:22098619,categories:["health"],significance:"well-established",riskAllele:"G",normalAllele:"A",trait:"CDKN2B-AS1 — Cardiovascular Disease",riskDescription:"Associated with increased coronary heart disease risk",normalDescription:"Average cardiovascular risk",heterozygousDescription:"Mildly elevated CHD risk",populationFrequency:{AA:.26,AG:.49,GG:.25},conditions:["Coronary heart disease","Type 2 diabetes"],recommendations:["Heart-healthy lifestyle","Regular check-ups"],references:["PMID:17478679"]},rs7903146:{rsid:"rs7903146",gene:"TCF7L2",chromosome:"10",position:114758349,categories:["health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"TCF7L2 — Type 2 Diabetes",riskDescription:"Strongest common genetic risk factor for type 2 diabetes (1.4x per allele)",normalDescription:"Average type 2 diabetes risk at this locus",heterozygousDescription:"Moderately increased T2D risk (~1.4x)",populationFrequency:{CC:.49,CT:.42,TT:.09},conditions:["Type 2 diabetes","Impaired insulin secretion","Gestational diabetes"],recommendations:["Regular glucose monitoring","Low glycemic index diet","Weight management","Regular exercise"],references:["PMID:16415884"]},rs2187668:{rsid:"rs2187668",gene:"HLA-DQA1",chromosome:"6",position:32605884,categories:["health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"HLA-DQ2.5 — Celiac Disease",riskDescription:"HLA-DQ2.5 haplotype: major genetic risk factor for celiac disease",normalDescription:"Absence of primary celiac risk haplotype",heterozygousDescription:"Carrier of HLA-DQ2.5: elevated celiac risk",populationFrequency:{CC:.72,CT:.25,TT:.03},conditions:["Celiac disease","Gluten sensitivity","Dermatitis herpetiformis"],recommendations:["Consider celiac antibody testing if symptomatic","Gluten-free diet if diagnosed"],references:["PMID:18311140"]},rs12255372:{rsid:"rs12255372",gene:"TCF7L2",chromosome:"10",position:114808902,categories:["health"],significance:"well-established",riskAllele:"T",normalAllele:"G",trait:"TCF7L2 — Type 2 Diabetes Risk",riskDescription:"Increased type 2 diabetes risk through impaired beta-cell function",normalDescription:"Normal beta-cell function at this locus",heterozygousDescription:"Moderately increased T2D risk",populationFrequency:{GG:.53,GT:.4,TT:.07},conditions:["Type 2 diabetes","Beta-cell dysfunction"],recommendations:["Blood glucose monitoring","Healthy diet and exercise"],references:["PMID:16415884"]},rs1801280:{rsid:"rs1801280",gene:"NAT2",chromosome:"8",position:18257854,categories:["health","pharma"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"NAT2 — Drug Acetylation Speed",riskDescription:"Slow acetylator: altered drug metabolism, increased drug toxicity risk",normalDescription:"Rapid acetylator: normal drug metabolism",heterozygousDescription:"Intermediate acetylator status",populationFrequency:{GG:.3,GA:.48,AA:.22},conditions:["Drug metabolism variation","Isoniazid toxicity risk","Bladder cancer risk (occupational)"],recommendations:["Inform physician of acetylator status","Dose adjustments for certain drugs"],references:["PMID:8807664"]},rs6025:{rsid:"rs6025",gene:"F5",chromosome:"1",position:169519049,categories:["health"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"Factor V Leiden — Blood Clotting",riskDescription:"Factor V Leiden mutation: 3-8x increased risk of venous thromboembolism",normalDescription:"Normal Factor V function",heterozygousDescription:"Heterozygous carrier: 3-5x VTE risk",populationFrequency:{CC:.95,CT:.047,TT:.003},conditions:["Deep vein thrombosis","Pulmonary embolism","Pregnancy complications"],recommendations:["Avoid prolonged immobility","Discuss with doctor before hormonal contraceptives","Compression stockings for travel"],references:["PMID:7989264"]},rs1799963:{rsid:"rs1799963",gene:"F2",chromosome:"11",position:46761055,categories:["health"],significance:"pathogenic",riskAllele:"A",normalAllele:"G",trait:"Prothrombin G20210A — Thrombophilia",riskDescription:"Elevated prothrombin levels, 2-5x increased VTE risk",normalDescription:"Normal prothrombin levels",heterozygousDescription:"Carrier: 2-3x VTE risk",populationFrequency:{GG:.97,GA:.029,AA:.001},conditions:["Venous thromboembolism","Stroke risk","Pregnancy loss"],recommendations:["Thrombophilia awareness","Discuss anticoagulation in high-risk situations"],references:["PMID:8844239"]},rs1800896:{rsid:"rs1800896",gene:"IL10",chromosome:"1",position:206773552,categories:["health"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"IL-10 — Anti-inflammatory Cytokine",riskDescription:"Lower IL-10 production, reduced anti-inflammatory capacity",normalDescription:"Higher IL-10 production, better anti-inflammatory response",heterozygousDescription:"Intermediate IL-10 production",populationFrequency:{GG:.25,GA:.5,AA:.25},conditions:["Inflammatory bowel disease","Rheumatoid arthritis","Transplant rejection"],recommendations:["Anti-inflammatory diet","Probiotics for gut health"],references:["PMID:9399958"]},rs1805010:{rsid:"rs1805010",gene:"IL4R",chromosome:"16",position:27363019,categories:["health"],significance:"moderate",riskAllele:"A",normalAllele:"G",trait:"IL-4Rα — Allergy & Asthma Susceptibility",riskDescription:"Increased susceptibility to allergic diseases and asthma",normalDescription:"Normal IL-4 receptor signaling",heterozygousDescription:"Moderately increased allergy risk",populationFrequency:{GG:.3,GA:.49,AA:.21},conditions:["Asthma","Allergic rhinitis","Atopic dermatitis"],recommendations:["Allergen avoidance","Consider allergy testing"],references:["PMID:10471617"]},rs2228145:{rsid:"rs2228145",gene:"IL6R",chromosome:"1",position:154426970,categories:["health"],significance:"well-established",riskAllele:"C",normalAllele:"A",trait:"IL-6R Asp358Ala — Inflammation",riskDescription:"Altered IL-6 signaling, cardiovascular implications",normalDescription:"Normal IL-6 receptor function",heterozygousDescription:"Intermediate IL-6R signaling",populationFrequency:{AA:.4,AC:.45,CC:.15},conditions:["Coronary heart disease","Rheumatoid arthritis","Systemic inflammation"],recommendations:["Monitor inflammatory markers (CRP)","Anti-inflammatory lifestyle"],references:["PMID:22158537"]},rs1048943:{rsid:"rs1048943",gene:"CYP1A1",chromosome:"15",position:75011882,categories:["health"],significance:"moderate",riskAllele:"G",normalAllele:"A",trait:"CYP1A1 — Xenobiotic Metabolism",riskDescription:"Increased activation of pro-carcinogens from tobacco smoke and environmental pollutants",normalDescription:"Normal xenobiotic metabolism",heterozygousDescription:"Moderately increased carcinogen activation",populationFrequency:{AA:.82,AG:.17,GG:.01},conditions:["Lung cancer risk (smokers)","Environmental toxin sensitivity"],recommendations:["Avoid tobacco smoke","Cruciferous vegetables (broccoli, kale)"],references:["PMID:2183157"]},rs4986893:{rsid:"rs4986893",gene:"CYP2C19",chromosome:"10",position:96540410,categories:["health","pharma"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"CYP2C19*3 — Drug Metabolism",riskDescription:"Poor metabolizer of CYP2C19 substrates including clopidogrel",normalDescription:"Normal CYP2C19 metabolism",heterozygousDescription:"Intermediate metabolizer",populationFrequency:{GG:.94,GA:.06,AA:.002},conditions:["Clopidogrel resistance","Proton pump inhibitor sensitivity"],recommendations:["Pharmacogenomic-guided prescribing","Alternative antiplatelet agents"],references:["PMID:18781855"]},rs11614913:{rsid:"rs11614913",gene:"MIR196A2",chromosome:"12",position:54385599,categories:["health"],significance:"moderate",riskAllele:"C",normalAllele:"T",trait:"miR-196a2 — Cancer Susceptibility",riskDescription:"Altered microRNA processing, associated with multiple cancer types",normalDescription:"Normal miR-196a2 expression",heterozygousDescription:"Moderately altered miRNA expression",populationFrequency:{TT:.3,TC:.48,CC:.22},conditions:["Breast cancer risk","Lung cancer risk","Gastric cancer risk"],recommendations:["Regular cancer screening","Healthy lifestyle"],references:["PMID:18250568"]},rs1695:{rsid:"rs1695",gene:"GSTP1",chromosome:"11",position:67585218,categories:["health"],significance:"well-established",riskAllele:"G",normalAllele:"A",trait:"GSTP1 — Detoxification Enzyme",riskDescription:"Reduced glutathione S-transferase activity, impaired detoxification",normalDescription:"Normal detoxification capacity",heterozygousDescription:"Mildly reduced detoxification",populationFrequency:{AA:.42,AG:.45,GG:.13},conditions:["Reduced xenobiotic detoxification","Cancer susceptibility","Chemotherapy response"],recommendations:["Cruciferous vegetables","Adequate glutathione precursors (NAC)"],references:["PMID:10702241"]},rs1229984:{rsid:"rs1229984",gene:"ADH1B",chromosome:"4",position:99318162,categories:["health","nutrition"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"ADH1B — Alcohol Metabolism",riskDescription:"Rapid alcohol to acetaldehyde conversion — protective against alcoholism but causes flushing",normalDescription:"Standard alcohol metabolism rate",heterozygousDescription:"Faster alcohol metabolism",populationFrequency:{CC:.7,CT:.26,TT:.04},conditions:["Alcohol flush reaction","Reduced alcoholism risk","Esophageal cancer risk with alcohol"],recommendations:["Limit alcohol consumption","Awareness of flush reaction"],references:["PMID:18385739"]},rs3892097:{rsid:"rs3892097",gene:"CYP2D6",chromosome:"22",position:42524947,categories:["pharma"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"CYP2D6*4 — Drug Metabolism",riskDescription:"Non-functional CYP2D6 allele: poor metabolizer of codeine, tamoxifen, many antidepressants",normalDescription:"Normal CYP2D6 metabolism",heterozygousDescription:"Intermediate metabolizer: reduced drug activation",populationFrequency:{GG:.56,GA:.37,AA:.07},conditions:["Poor drug metabolism","Codeine non-response","Tamoxifen reduced efficacy"],recommendations:["Pharmacogenomic card for healthcare providers","Alternative pain medications to codeine","Tamoxifen alternatives if applicable"],references:["PMID:15625273"]},rs1065852:{rsid:"rs1065852",gene:"CYP2D6",chromosome:"22",position:42526694,categories:["pharma"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"CYP2D6*10 — Reduced Drug Metabolism",riskDescription:"Reduced CYP2D6 activity affecting metabolism of many medications",normalDescription:"Normal CYP2D6 function",heterozygousDescription:"Intermediate metabolizer",populationFrequency:{GG:.5,GA:.4,AA:.1},conditions:["Reduced drug metabolism","Increased drug sensitivity"],recommendations:["Dose adjustments may be needed","Inform prescribers"],references:["PMID:19512959"]},rs4244285:{rsid:"rs4244285",gene:"CYP2C19",chromosome:"10",position:96541616,categories:["pharma"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"CYP2C19*2 — Clopidogrel Response",riskDescription:"Poor CYP2C19 metabolizer: clopidogrel (Plavix) may be ineffective",normalDescription:"Normal clopidogrel activation",heterozygousDescription:"Intermediate metabolizer: reduced clopidogrel efficacy",populationFrequency:{GG:.6,GA:.34,AA:.06},conditions:["Clopidogrel resistance","PPI altered metabolism","Antidepressant dose sensitivity"],recommendations:["FDA boxed warning on clopidogrel","Consider prasugrel or ticagrelor alternatives","PPI dose adjustment"],references:["PMID:19706858"]},rs12248560:{rsid:"rs12248560",gene:"CYP2C19",chromosome:"10",position:96522463,categories:["pharma"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"CYP2C19*17 — Ultra-Rapid Metabolism",riskDescription:"Ultra-rapid CYP2C19 metabolizer: faster drug processing, may need higher doses",normalDescription:"Normal CYP2C19 metabolism speed",heterozygousDescription:"Rapid metabolizer: somewhat faster drug processing",populationFrequency:{CC:.55,CT:.38,TT:.07},conditions:["Ultra-rapid drug metabolism","Possible therapeutic failure at standard doses"],recommendations:["May need dose increases for clopidogrel, PPIs, some antidepressants"],references:["PMID:16958828"]},rs762551:{rsid:"rs762551",gene:"CYP1A2",chromosome:"15",position:75041917,categories:["pharma","nutrition"],significance:"well-established",riskAllele:"C",normalAllele:"A",trait:"CYP1A2 — Caffeine Metabolism",riskDescription:"Slow caffeine metabolizer: caffeine stays in system longer, increased cardiovascular risk with high coffee intake",normalDescription:"Fast caffeine metabolizer: rapid caffeine clearance",heterozygousDescription:"Intermediate caffeine metabolism",populationFrequency:{AA:.46,AC:.44,CC:.1},conditions:["Slow caffeine metabolism","Insomnia from caffeine","Heart attack risk with >3 cups coffee/day"],recommendations:["Limit caffeine to 1-2 cups/day if slow metabolizer","No caffeine after noon","Switch to decaf or tea"],references:["PMID:16522833"]},rs9923231:{rsid:"rs9923231",gene:"VKORC1",chromosome:"16",position:31096368,categories:["pharma"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"VKORC1 — Warfarin Sensitivity",riskDescription:"Increased warfarin sensitivity: requires significantly lower doses",normalDescription:"Standard warfarin dose requirements",heterozygousDescription:"Intermediate warfarin sensitivity: moderate dose reduction",populationFrequency:{CC:.37,CT:.47,TT:.16},conditions:["Warfarin dose sensitivity","Bleeding risk with standard doses"],recommendations:["FDA-recommended pharmacogenomic dosing for warfarin","Start with lower doses","More frequent INR monitoring"],references:["PMID:15930419"]},rs4149056:{rsid:"rs4149056",gene:"SLCO1B1",chromosome:"12",position:21331549,categories:["pharma"],significance:"well-established",riskAllele:"C",normalAllele:"T",trait:"SLCO1B1 — Statin Myopathy Risk",riskDescription:"Increased risk of statin-induced myopathy (muscle pain/damage), especially with simvastatin",normalDescription:"Normal statin tolerance",heterozygousDescription:"Moderately increased myopathy risk (~4.5x with simvastatin)",populationFrequency:{TT:.73,TC:.25,CC:.02},conditions:["Statin-induced myopathy","Rhabdomyolysis risk","Simvastatin intolerance"],recommendations:["Avoid high-dose simvastatin","Consider rosuvastatin or pravastatin","Monitor CK levels"],references:["PMID:18650507"]},rs1057910:{rsid:"rs1057910",gene:"CYP2C9",chromosome:"10",position:96702047,categories:["pharma"],significance:"well-established",riskAllele:"C",normalAllele:"A",trait:"CYP2C9*3 — Drug Metabolism",riskDescription:"Significantly reduced CYP2C9 activity: affects warfarin, NSAIDs, phenytoin metabolism",normalDescription:"Normal CYP2C9 metabolism",heterozygousDescription:"Intermediate metabolizer: reduced clearance of CYP2C9 substrates",populationFrequency:{AA:.85,AC:.14,CC:.01},conditions:["Warfarin sensitivity","NSAID toxicity risk","Phenytoin toxicity risk"],recommendations:["Reduced warfarin doses needed","NSAID caution","Therapeutic drug monitoring"],references:["PMID:10208644"]},rs1799853:{rsid:"rs1799853",gene:"CYP2C9",chromosome:"10",position:96698440,categories:["pharma"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"CYP2C9*2 — Warfarin & NSAID Metabolism",riskDescription:"Reduced CYP2C9 activity affecting warfarin and NSAID processing",normalDescription:"Normal CYP2C9*1 function",heterozygousDescription:"Intermediate metabolizer",populationFrequency:{CC:.78,CT:.2,TT:.02},conditions:["Warfarin dose sensitivity","NSAID adverse effects"],recommendations:["Lower warfarin starting dose","Monitor for NSAID side effects"],references:["PMID:10208644"]},rs4148323:{rsid:"rs4148323",gene:"UGT1A1",chromosome:"2",position:234669144,categories:["pharma"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"UGT1A1*6 — Irinotecan Toxicity",riskDescription:"Reduced UGT1A1 activity: increased risk of irinotecan toxicity",normalDescription:"Normal bilirubin conjugation and drug metabolism",heterozygousDescription:"Intermediate UGT1A1 activity",populationFrequency:{GG:.8,GA:.18,AA:.02},conditions:["Irinotecan toxicity","Gilbert syndrome","Hyperbilirubinemia"],recommendations:["Irinotecan dose reduction if applicable","Monitor bilirubin levels"],references:["PMID:17510684"]},rs28399504:{rsid:"rs28399504",gene:"CYP2C19",chromosome:"10",position:96522613,categories:["pharma"],significance:"well-established",riskAllele:"G",normalAllele:"A",trait:"CYP2C19*4 — Drug Metabolism Variant",riskDescription:"Non-functional CYP2C19 allele",normalDescription:"Normal CYP2C19 function",heterozygousDescription:"Intermediate metabolizer",populationFrequency:{AA:.995,AG:.005,GG:0},conditions:["Poor CYP2C19 metabolism"],recommendations:["Consider alternative medications to CYP2C19 substrates"],references:["PMID:14657094"]},rs1128503:{rsid:"rs1128503",gene:"ABCB1",chromosome:"7",position:87550285,categories:["pharma"],significance:"moderate",riskAllele:"T",normalAllele:"C",trait:"ABCB1/MDR1 — Drug Transport",riskDescription:"Altered P-glycoprotein expression affecting drug absorption and distribution",normalDescription:"Normal drug transport",heterozygousDescription:"Intermediate drug transport efficiency",populationFrequency:{CC:.32,CT:.48,TT:.2},conditions:["Altered drug bioavailability","Digoxin sensitivity","Immunosuppressant levels"],recommendations:["Therapeutic drug monitoring for P-gp substrates"],references:["PMID:10858656"]},rs2032582:{rsid:"rs2032582",gene:"ABCB1",chromosome:"7",position:87531302,categories:["pharma"],significance:"moderate",riskAllele:"T",normalAllele:"G",trait:"ABCB1 Ser893Ala — Drug Efflux",riskDescription:"Modified P-glycoprotein function affecting multiple drug classes",normalDescription:"Normal P-glycoprotein efflux activity",heterozygousDescription:"Intermediate P-gp function",populationFrequency:{GG:.3,GT:.5,TT:.2},conditions:["Drug disposition variation","Cancer drug resistance"],recommendations:["Consider in polypharmacy situations"],references:["PMID:11305860"]},rs1045642:{rsid:"rs1045642",gene:"ABCB1",chromosome:"7",position:87509329,categories:["pharma"],significance:"moderate",riskAllele:"T",normalAllele:"C",trait:"ABCB1 C3435T — Drug Absorption",riskDescription:"Reduced P-glycoprotein expression, altered drug levels",normalDescription:"Normal P-glycoprotein expression",heterozygousDescription:"Intermediate expression levels",populationFrequency:{CC:.26,CT:.5,TT:.24},conditions:["Increased digoxin levels","Cyclosporine sensitivity","HIV protease inhibitor levels"],recommendations:["Drug level monitoring when relevant"],references:["PMID:10858656"]},rs4633:{rsid:"rs4633",gene:"COMT",chromosome:"22",position:19950235,categories:["pharma","traits"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"COMT — Catechol Metabolism",riskDescription:"Lower COMT activity, slower dopamine/catecholamine breakdown",normalDescription:"Normal COMT activity, efficient catecholamine clearance",heterozygousDescription:"Intermediate COMT activity",populationFrequency:{CC:.25,CT:.5,TT:.25},conditions:["Pain sensitivity variation","Stress response","Estrogen metabolism"],recommendations:["Stress management techniques","Magnesium supplementation"],references:["PMID:15514402"]},rs4680:{rsid:"rs4680",gene:"COMT",chromosome:"22",position:19963748,categories:["pharma","traits"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"COMT Val158Met — Warrior vs Worrier",riskDescription:"Met/Met (Worrier): higher prefrontal dopamine, better cognition under low stress but anxious under high stress",normalDescription:"Val/Val (Warrior): lower prefrontal dopamine, stress-resilient but lower baseline cognition",heterozygousDescription:"Val/Met: balanced dopamine metabolism",populationFrequency:{GG:.25,GA:.5,AA:.25},conditions:["Stress resilience variation","Pain sensitivity","Cognitive style"],recommendations:["Adapt stress management to genotype","Mindfulness for Met carriers"],references:["PMID:15514402"]},rs9332131:{rsid:"rs9332131",gene:"CYP2C9",chromosome:"10",position:96709038,categories:["pharma"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"CYP2C9*6 — Drug Metabolism",riskDescription:"Non-functional CYP2C9 allele affecting warfarin and NSAID metabolism",normalDescription:"Normal CYP2C9 function",heterozygousDescription:"Intermediate metabolizer",populationFrequency:{GG:.99,GA:.01,AA:0},conditions:["Warfarin hypersensitivity","NSAID toxicity"],recommendations:["Significant warfarin dose reduction","NSAID alternatives"],references:["PMID:15625273"]},rs3745274:{rsid:"rs3745274",gene:"CYP2B6",chromosome:"19",position:41512841,categories:["pharma"],significance:"well-established",riskAllele:"T",normalAllele:"G",trait:"CYP2B6*6 — Efavirenz Metabolism",riskDescription:"Reduced CYP2B6 activity: elevated efavirenz levels, CNS side effects",normalDescription:"Normal CYP2B6 metabolism",heterozygousDescription:"Intermediate metabolizer",populationFrequency:{GG:.55,GT:.38,TT:.07},conditions:["Efavirenz toxicity","Cyclophosphamide metabolism","Bupropion levels"],recommendations:["Efavirenz dose adjustment","Monitor for CNS side effects"],references:["PMID:15625273"]},rs28371725:{rsid:"rs28371725",gene:"CYP2D6",chromosome:"22",position:42524435,categories:["pharma"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"CYP2D6*41 — Reduced Drug Metabolism",riskDescription:"Decreased CYP2D6 function, intermediate metabolizer",normalDescription:"Normal CYP2D6 activity",heterozygousDescription:"Slightly reduced metabolism",populationFrequency:{CC:.9,CT:.09,TT:.01},conditions:["Reduced metabolism of CYP2D6 substrates"],recommendations:["Consider dose adjustments for CYP2D6-metabolized drugs"],references:["PMID:16958828"]},rs1801133:{rsid:"rs1801133",gene:"MTHFR",chromosome:"1",position:11856378,categories:["nutrition","health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"MTHFR C677T — Methylation",riskDescription:"Reduced MTHFR enzyme activity affecting folate metabolism (~30% activity when homozygous)",normalDescription:"Normal MTHFR enzyme activity",heterozygousDescription:"Mildly reduced MTHFR activity (~65% normal)",populationFrequency:{CC:.44,CT:.42,TT:.14},conditions:["Elevated homocysteine","Folate deficiency risk","Neural tube defect risk"],recommendations:["Consider methylfolate (5-MTHF) over folic acid","Monitor homocysteine levels","B12 supplementation"],references:["PMID:15060097"]},rs1801131:{rsid:"rs1801131",gene:"MTHFR",chromosome:"1",position:11854476,categories:["nutrition","health"],significance:"well-established",riskAllele:"G",normalAllele:"T",trait:"MTHFR A1298C — Methylation",riskDescription:"Reduced MTHFR activity, compounded effect with C677T",normalDescription:"Normal MTHFR function at this position",heterozygousDescription:"Mildly reduced MTHFR activity",populationFrequency:{TT:.45,TG:.43,GG:.12},conditions:["Reduced methylation capacity","Homocysteine elevation (with C677T)"],recommendations:["Methylfolate supplementation","Check compound heterozygosity with C677T"],references:["PMID:10930360"]},rs4988235:{rsid:"rs4988235",gene:"MCM6",chromosome:"2",position:136608646,categories:["nutrition"],significance:"well-established",riskAllele:"G",normalAllele:"A",trait:"MCM6/LCT — Lactose Tolerance",riskDescription:"Lactase non-persistence: lactose intolerance in adulthood",normalDescription:"Lactase persistence: can digest dairy throughout life",heterozygousDescription:"Likely lactose tolerant (dominant trait)",populationFrequency:{AA:.35,AG:.42,GG:.23},conditions:["Lactose intolerance","Dairy maldigestion"],recommendations:["Lactase enzyme supplements with dairy","Calcium from non-dairy sources","Fermented dairy may be tolerated"],references:["PMID:11788828"]},rs671:{rsid:"rs671",gene:"ALDH2",chromosome:"12",position:112241766,categories:["nutrition","health"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"ALDH2*2 — Alcohol Flush Reaction",riskDescription:"Severely reduced aldehyde dehydrogenase: alcohol flush, acetaldehyde accumulation, esophageal cancer risk",normalDescription:"Normal alcohol metabolism",heterozygousDescription:"Partial enzyme deficiency: flushing with alcohol, cancer risk if drinking",populationFrequency:{GG:.72,GA:.24,AA:.04},conditions:["Alcohol flush reaction","Esophageal cancer risk with alcohol","Acetaldehyde toxicity"],recommendations:["Avoid or strictly limit alcohol","Never drink through the flush","No nitroglycerin patches"],references:["PMID:19448012"]},rs9939609:{rsid:"rs9939609",gene:"FTO",chromosome:"16",position:53820527,categories:["nutrition","health"],significance:"well-established",riskAllele:"A",normalAllele:"T",trait:"FTO — Obesity Risk",riskDescription:"Increased appetite, higher BMI (average 1.5-3 kg per allele), obesity risk",normalDescription:"Average weight regulation at this locus",heterozygousDescription:"Moderate obesity risk (1.2x)",populationFrequency:{TT:.34,TA:.46,AA:.2},conditions:["Obesity susceptibility","Increased appetite","Type 2 diabetes risk"],recommendations:["Portion control","High protein diet may counteract FTO effects","Regular exercise","Mindful eating"],references:["PMID:17434869"]},rs2228570:{rsid:"rs2228570",gene:"VDR",chromosome:"12",position:48272895,categories:["nutrition"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"VDR FokI — Vitamin D Receptor",riskDescription:"Less active vitamin D receptor: may need higher vitamin D intake",normalDescription:"More active VDR: efficient vitamin D utilization",heterozygousDescription:"Intermediate vitamin D receptor activity",populationFrequency:{CC:.35,CT:.48,TT:.17},conditions:["Vitamin D deficiency susceptibility","Bone health","Immune function"],recommendations:["Monitor 25(OH)D levels","Consider higher vitamin D supplementation (2000-4000 IU)","Sun exposure"],references:["PMID:10632262"]},rs1800562:{rsid:"rs1800562",gene:"HFE",chromosome:"6",position:26093141,categories:["nutrition","health"],significance:"well-established",riskAllele:"A",normalAllele:"G",trait:"HFE C282Y — Hereditary Hemochromatosis",riskDescription:"Homozygous: hereditary hemochromatosis with iron overload. Carrier: mild iron elevation",normalDescription:"Normal iron regulation",heterozygousDescription:"Carrier: mildly increased iron absorption, usually asymptomatic",populationFrequency:{GG:.87,GA:.12,AA:.01},conditions:["Hereditary hemochromatosis","Iron overload","Liver disease","Joint pain"],recommendations:["Regular ferritin and transferrin saturation testing","Avoid iron supplements unless deficient","Limit vitamin C with meals (enhances iron absorption)","Blood donation helps"],references:["PMID:8696333"]},rs1799945:{rsid:"rs1799945",gene:"HFE",chromosome:"6",position:26091179,categories:["nutrition","health"],significance:"well-established",riskAllele:"G",normalAllele:"C",trait:"HFE H63D — Iron Metabolism",riskDescription:"Mildly increased iron absorption, risk with compound heterozygosity (C282Y)",normalDescription:"Normal iron regulation",heterozygousDescription:"Slightly elevated iron levels, usually benign alone",populationFrequency:{CC:.72,CG:.25,GG:.03},conditions:["Mild iron elevation","Compound hemochromatosis risk"],recommendations:["Check ferritin levels periodically","Assess C282Y status"],references:["PMID:8696333"]},rs4654748:{rsid:"rs4654748",gene:"NBPF3",chromosome:"1",position:17345640,categories:["nutrition"],significance:"moderate",riskAllele:"T",normalAllele:"C",trait:"Vitamin B6 Levels",riskDescription:"Lower circulating vitamin B6 levels",normalDescription:"Normal vitamin B6 levels",heterozygousDescription:"Slightly lower B6 levels",populationFrequency:{CC:.3,CT:.48,TT:.22},conditions:["Vitamin B6 deficiency risk"],recommendations:["Consider B6 supplementation","B6-rich foods (poultry, fish, potatoes)"],references:["PMID:19744961"]},rs12934922:{rsid:"rs12934922",gene:"BCMO1",chromosome:"16",position:81264597,categories:["nutrition"],significance:"moderate",riskAllele:"T",normalAllele:"A",trait:"BCMO1 — Beta-Carotene Conversion",riskDescription:"Reduced ability to convert beta-carotene to vitamin A (~50% reduction when homozygous)",normalDescription:"Normal beta-carotene to vitamin A conversion",heterozygousDescription:"Moderately reduced conversion (~30% reduction)",populationFrequency:{AA:.3,AT:.48,TT:.22},conditions:["Poor beta-carotene converter","Vitamin A deficiency risk on vegan diet"],recommendations:["Pre-formed vitamin A (retinol) from animal sources or supplements","Don't rely solely on beta-carotene for vitamin A"],references:["PMID:19103647"]},rs7946:{rsid:"rs7946",gene:"PEMT",chromosome:"17",position:17409572,categories:["nutrition"],significance:"moderate",riskAllele:"T",normalAllele:"C",trait:"PEMT — Choline Synthesis",riskDescription:"Reduced phosphatidylethanolamine N-methyltransferase: higher dietary choline needs",normalDescription:"Normal endogenous choline production",heterozygousDescription:"Slightly increased choline requirements",populationFrequency:{CC:.35,CT:.48,TT:.17},conditions:["Choline deficiency susceptibility","Non-alcoholic fatty liver risk"],recommendations:["Ensure adequate choline intake (eggs, liver, cruciferous vegetables)"],references:["PMID:16702348"]},rs602662:{rsid:"rs602662",gene:"FUT2",chromosome:"19",position:49206674,categories:["nutrition"],significance:"moderate",riskAllele:"A",normalAllele:"G",trait:"FUT2 — Vitamin B12 Absorption",riskDescription:"Non-secretor status: reduced B12 absorption in gut",normalDescription:"Secretor status: normal B12 absorption",heterozygousDescription:"Intermediate B12 absorption",populationFrequency:{GG:.45,GA:.42,AA:.13},conditions:["Vitamin B12 deficiency risk","Gut microbiome variation"],recommendations:["Monitor B12 levels","Consider sublingual B12","Regular testing if vegan/vegetarian"],references:["PMID:23754956"]},rs174547:{rsid:"rs174547",gene:"FADS1",chromosome:"11",position:61597212,categories:["nutrition"],significance:"well-established",riskAllele:"C",normalAllele:"T",trait:"FADS1 — Omega-3/6 Fatty Acid Conversion",riskDescription:"Reduced conversion of ALA to EPA/DHA omega-3 fatty acids",normalDescription:"Efficient omega-3 fatty acid conversion",heterozygousDescription:"Moderately reduced conversion",populationFrequency:{TT:.34,TC:.48,CC:.18},conditions:["Omega-3 deficiency risk","Inflammatory balance"],recommendations:["Direct EPA/DHA sources (fish oil, fatty fish)","Don't rely on ALA (flax/chia) alone"],references:["PMID:21829377"]},rs1544410:{rsid:"rs1544410",gene:"VDR",chromosome:"12",position:48239835,categories:["nutrition"],significance:"moderate",riskAllele:"A",normalAllele:"G",trait:"VDR BsmI — Vitamin D Utilization",riskDescription:"Altered vitamin D receptor expression, may need more vitamin D",normalDescription:"Normal vitamin D receptor expression",heterozygousDescription:"Intermediate VDR expression",populationFrequency:{GG:.3,GA:.48,AA:.22},conditions:["Bone mineral density variation","Vitamin D requirements"],recommendations:["Check vitamin D levels","Supplement if low"],references:["PMID:9843978"]},rs7041:{rsid:"rs7041",gene:"GC",chromosome:"4",position:72618334,categories:["nutrition"],significance:"well-established",riskAllele:"G",normalAllele:"T",trait:"GC/DBP — Vitamin D Binding Protein",riskDescription:"Lower vitamin D binding protein levels, may have lower total 25(OH)D",normalDescription:"Normal vitamin D binding and transport",heterozygousDescription:"Intermediate vitamin D binding protein levels",populationFrequency:{TT:.3,TG:.48,GG:.22},conditions:["Altered vitamin D bioavailability","Lower total 25(OH)D levels"],recommendations:["Free 25(OH)D may be more informative","Adequate supplementation"],references:["PMID:20541252"]},rs1260326:{rsid:"rs1260326",gene:"GCKR",chromosome:"2",position:27730940,categories:["nutrition","health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"GCKR — Glucose/Lipid Metabolism",riskDescription:"Higher triglycerides but lower fasting glucose (paradoxical)",normalDescription:"Standard glucose-lipid metabolism",heterozygousDescription:"Intermediate metabolic effects",populationFrequency:{CC:.28,CT:.49,TT:.23},conditions:["Elevated triglycerides","Lower fasting glucose","Metabolic trait"],recommendations:["Monitor triglyceride levels","Omega-3 for triglyceride management"],references:["PMID:21423719"]},rs4588:{rsid:"rs4588",gene:"GC",chromosome:"4",position:72618323,categories:["nutrition"],significance:"well-established",riskAllele:"A",normalAllele:"C",trait:"GC — Vitamin D Binding & Transport",riskDescription:"Lower DBP concentration, altered vitamin D transport",normalDescription:"Normal DBP and vitamin D transport",heterozygousDescription:"Intermediate DBP levels",populationFrequency:{CC:.5,CA:.4,AA:.1},conditions:["Vitamin D transport variation"],recommendations:["Consider bio-available vitamin D testing"],references:["PMID:20541252"]},rs12913832:{rsid:"rs12913832",gene:"HERC2/OCA2",chromosome:"15",position:28365618,categories:["traits"],significance:"well-established",riskAllele:"G",normalAllele:"A",trait:"HERC2/OCA2 — Eye Color",riskDescription:"GG: very high probability of blue eyes",normalDescription:"AA: brown eyes most likely",heterozygousDescription:"AG: likely green/hazel eyes, possibly blue",populationFrequency:{AA:.36,AG:.4,GG:.24},conditions:["Eye color determination"],recommendations:["UV protection for light eyes (more sensitive to sunlight)"],references:["PMID:18172690"]},rs1805007:{rsid:"rs1805007",gene:"MC1R",chromosome:"16",position:89986117,categories:["traits","health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"MC1R R151C — Red Hair & Skin Sensitivity",riskDescription:"Strong red hair predictor, fair skin, increased melanoma risk, pain sensitivity",normalDescription:"Normal melanin production",heterozygousDescription:"Carrier: may have reddish tint, freckling, increased sun sensitivity",populationFrequency:{CC:.87,CT:.12,TT:.01},conditions:["Red hair","Fair skin","Melanoma susceptibility","Altered pain/anesthesia sensitivity"],recommendations:["Rigorous sun protection (SPF 50+)","Regular skin cancer screening","Inform anesthesiologist (may need more anesthesia)"],references:["PMID:11260224"]},rs1815739:{rsid:"rs1815739",gene:"ACTN3",chromosome:"11",position:66560624,categories:["traits"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"ACTN3 R577X — Muscle Fiber Type",riskDescription:"XX genotype: no alpha-actinin-3, endurance advantage, less sprint power",normalDescription:"RR genotype: full alpha-actinin-3, sprint/power advantage",heterozygousDescription:"RX: intermediate — good at both power and endurance",populationFrequency:{CC:.3,CT:.52,TT:.18},conditions:["Athletic performance type","Muscle fiber composition"],recommendations:["Tailor training to genotype (endurance vs power)","XX: focus on endurance sports","RR: explosive/power training may be optimal"],references:["PMID:12879365"]},rs2304672:{rsid:"rs2304672",gene:"PER2",chromosome:"2",position:239153925,categories:["traits"],significance:"moderate",riskAllele:"G",normalAllele:"C",trait:"PER2 — Circadian Rhythm / Sleep",riskDescription:"Altered circadian rhythm, tendency toward being a morning person (advanced sleep phase)",normalDescription:"Standard circadian rhythm timing",heterozygousDescription:"Mildly shifted circadian preference",populationFrequency:{CC:.82,CG:.17,GG:.01},conditions:["Advanced sleep phase","Morning chronotype"],recommendations:["Align schedule with chronotype","Light exposure management"],references:["PMID:11232563"]},rs713598:{rsid:"rs713598",gene:"TAS2R38",chromosome:"7",position:141672604,categories:["traits","nutrition"],significance:"well-established",riskAllele:"G",normalAllele:"C",trait:"TAS2R38 — Bitter Taste Perception",riskDescription:"Reduced bitter taste sensitivity (non-taster): may consume more cruciferous vegetables",normalDescription:"Strong bitter taste sensitivity (supertaster): may avoid bitter foods",heterozygousDescription:"Medium taster: moderate bitter perception",populationFrequency:{CC:.2,CG:.49,GG:.31},conditions:["Bitter taste perception","Food preferences","Vegetable consumption patterns"],recommendations:["Supertasters: try preparing bitter vegetables with fat/salt to mask bitterness","Non-tasters: ensure adequate vegetable intake isn't compromised"],references:["PMID:12595690"]},rs53576:{rsid:"rs53576",gene:"OXTR",chromosome:"3",position:8804371,categories:["traits"],significance:"moderate",riskAllele:"A",normalAllele:"G",trait:"OXTR — Oxytocin Receptor / Empathy",riskDescription:"Reduced oxytocin receptor expression: may affect social bonding and empathy",normalDescription:"Higher oxytocin receptor expression: stronger empathy and social sensitivity",heterozygousDescription:"Intermediate social-emotional sensitivity",populationFrequency:{GG:.4,GA:.44,AA:.16},conditions:["Social cognition variation","Empathy differences","Stress response"],recommendations:["Social connection is important regardless of genotype","Mindfulness and compassion practices"],references:["PMID:19934046"]},rs4950:{rsid:"rs4950",gene:"MSRA",chromosome:"8",position:10081204,categories:["traits"],significance:"moderate",riskAllele:"G",normalAllele:"A",trait:"Leadership Tendency",riskDescription:"Associated with leadership role occupancy in GWAS studies",normalDescription:"Average leadership tendency at this locus",heterozygousDescription:"Intermediate association",populationFrequency:{AA:.4,AG:.44,GG:.16},conditions:["Leadership behavior"],recommendations:["Environmental factors are much more important than genetics for leadership"],references:["PMID:23213369"]},rs1800955:{rsid:"rs1800955",gene:"DRD4",chromosome:"11",position:637315,categories:["traits"],significance:"moderate",riskAllele:"C",normalAllele:"T",trait:"DRD4 — Novelty Seeking",riskDescription:"Higher dopamine D4 receptor expression, associated with novelty seeking",normalDescription:"Standard D4 receptor levels",heterozygousDescription:"Intermediate novelty seeking tendency",populationFrequency:{TT:.3,TC:.48,CC:.22},conditions:["Novelty seeking behavior","ADHD association"],recommendations:["Channel novelty seeking productively","Varied activities and experiences"],references:["PMID:8900340"]},rs1800544:{rsid:"rs1800544",gene:"ADRA2A",chromosome:"10",position:112836655,categories:["traits"],significance:"moderate",riskAllele:"G",normalAllele:"C",trait:"ADRA2A — Attention & Focus",riskDescription:"Altered adrenergic receptor function, associated with attention variation",normalDescription:"Normal adrenergic attention regulation",heterozygousDescription:"Intermediate attention regulation",populationFrequency:{CC:.35,CG:.47,GG:.18},conditions:["Attention regulation","Working memory"],recommendations:["Regular breaks during focused work","Exercise improves attention"],references:["PMID:10903899"]},rs1800588:{rsid:"rs1800588",gene:"LIPC",chromosome:"15",position:58723675,categories:["traits","health"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"LIPC — HDL Cholesterol Levels",riskDescription:"Lower hepatic lipase activity, generally higher HDL cholesterol",normalDescription:"Normal hepatic lipase activity",heterozygousDescription:"Intermediate HDL levels",populationFrequency:{CC:.5,CT:.4,TT:.1},conditions:["HDL cholesterol variation"],recommendations:["Regular lipid panel testing","Heart-healthy lifestyle"],references:["PMID:10391209"]},rs4570625:{rsid:"rs4570625",gene:"TPH2",chromosome:"12",position:72332381,categories:["traits"],significance:"moderate",riskAllele:"T",normalAllele:"G",trait:"TPH2 — Serotonin Synthesis",riskDescription:"Altered tryptophan hydroxylase-2 activity affecting brain serotonin synthesis",normalDescription:"Normal brain serotonin synthesis",heterozygousDescription:"Mildly altered serotonin synthesis",populationFrequency:{GG:.6,GT:.34,TT:.06},conditions:["Mood regulation","Anxiety susceptibility","Emotional reactivity"],recommendations:["Adequate tryptophan intake","Regular exercise (boosts serotonin)","Sunlight exposure"],references:["PMID:15866551"]},rs6311:{rsid:"rs6311",gene:"HTR2A",chromosome:"13",position:47471478,categories:["traits"],significance:"moderate",riskAllele:"A",normalAllele:"G",trait:"HTR2A — Serotonin 2A Receptor",riskDescription:"Altered serotonin 2A receptor expression",normalDescription:"Normal 5-HT2A receptor density",heterozygousDescription:"Intermediate receptor expression",populationFrequency:{GG:.3,GA:.48,AA:.22},conditions:["SSRI response variation","Sleep quality","Mood regulation"],recommendations:["Discuss SSRI response with prescriber","Good sleep hygiene"],references:["PMID:11958969"]},rs1805009:{rsid:"rs1805009",gene:"MC1R",chromosome:"16",position:89986546,categories:["traits"],significance:"well-established",riskAllele:"C",normalAllele:"G",trait:"MC1R D294H — Red Hair & Fair Skin",riskDescription:"Strong red hair and fair skin variant, melanoma risk",normalDescription:"Normal pigmentation",heterozygousDescription:"Carrier: possible fair skin traits",populationFrequency:{GG:.96,GC:.04,CC:.001},conditions:["Red hair","UV sensitivity","Melanoma risk"],recommendations:["Sun protection","Regular dermatology check-ups"],references:["PMID:11260224"]},rs1805008:{rsid:"rs1805008",gene:"MC1R",chromosome:"16",position:89986154,categories:["traits"],significance:"well-established",riskAllele:"T",normalAllele:"C",trait:"MC1R R160W — Red Hair Variant",riskDescription:"Red hair and fair skin predisposition",normalDescription:"Normal MC1R function",heterozygousDescription:"Carrier of red hair variant",populationFrequency:{CC:.9,CT:.09,TT:.01},conditions:["Red/auburn hair","Fair skin","Sun sensitivity"],recommendations:["Rigorous sun protection"],references:["PMID:11260224"]},rs75527207:{rsid:"rs75527207",gene:"CFTR",chromosome:"7",position:117559590,categories:["carrier"],significance:"pathogenic",riskAllele:"A",normalAllele:"G",trait:"CFTR ΔF508 — Cystic Fibrosis",riskDescription:"Most common CF mutation. Homozygous: cystic fibrosis. Carrier: unaffected",normalDescription:"No ΔF508 mutation detected",heterozygousDescription:"CF carrier: 1 in 25 Caucasians. Relevant for family planning",populationFrequency:{GG:.96,GA:.039,AA:.001},conditions:["Cystic fibrosis (homozygous)","CF carrier status"],recommendations:["Genetic counseling if carrier","Partner carrier testing recommended","Family planning discussion"],references:["PMID:2475911"]},rs334:{rsid:"rs334",gene:"HBB",chromosome:"11",position:5227002,categories:["carrier","health"],significance:"pathogenic",riskAllele:"T",normalAllele:"A",trait:"HBB — Sickle Cell Trait",riskDescription:"HbS mutation. Homozygous: sickle cell disease. Carrier: sickle cell trait (malaria resistance)",normalDescription:"Normal hemoglobin",heterozygousDescription:"Sickle cell trait: generally asymptomatic, malaria resistance, rare exercise complications",populationFrequency:{AA:.92,AT:.07,TT:.01},conditions:["Sickle cell disease (homozygous)","Sickle cell trait (carrier)","Malaria resistance (carrier)"],recommendations:["Genetic counseling","Carrier partner testing","Hydration during intense exercise","Altitude awareness"],references:["PMID:2288582"]},rs80338939:{rsid:"rs80338939",gene:"GJB2",chromosome:"13",position:20763612,categories:["carrier"],significance:"pathogenic",riskAllele:"A",normalAllele:"G",trait:"GJB2 35delG — Hearing Loss",riskDescription:"Most common cause of autosomal recessive non-syndromic hearing loss",normalDescription:"Normal connexin-26 function",heterozygousDescription:"Carrier: normal hearing, family planning relevance",populationFrequency:{GG:.96,GA:.038,AA:.002},conditions:["Non-syndromic hearing loss (homozygous)","DFNB1 carrier"],recommendations:["Genetic counseling for carriers","Partner testing","Newborn hearing screening awareness"],references:["PMID:9771706"]},rs28937594:{rsid:"rs28937594",gene:"HEXA",chromosome:"15",position:72638892,categories:["carrier"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"HEXA — Tay-Sachs Disease",riskDescription:"Carrier of Tay-Sachs disease mutation",normalDescription:"Normal hexosaminidase A activity",heterozygousDescription:"Carrier: unaffected, family planning relevance",populationFrequency:{CC:.97,CT:.03,TT:3e-4},conditions:["Tay-Sachs disease (homozygous)","Carrier status"],recommendations:["Genetic counseling","Partner carrier screening","Common in Ashkenazi Jewish population"],references:["PMID:8401469"]},rs76151636:{rsid:"rs76151636",gene:"SMN1",chromosome:"5",position:70247773,categories:["carrier"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"SMN1 — Spinal Muscular Atrophy",riskDescription:"SMA carrier: 1 in 40-60 people carry a deletion/mutation",normalDescription:"Normal SMN1 function",heterozygousDescription:"SMA carrier: relevant for family planning",populationFrequency:{CC:.975,CT:.024,TT:.001},conditions:["Spinal muscular atrophy (homozygous)","SMA carrier"],recommendations:["Genetic counseling","Partner screening","SMA newborn screening available"],references:["PMID:7677801"]},rs11970772:{rsid:"rs11970772",gene:"PAH",chromosome:"12",position:103234207,categories:["carrier"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"PAH — Phenylketonuria (PKU)",riskDescription:"PKU carrier: phenylalanine hydroxylase deficiency",normalDescription:"Normal phenylalanine metabolism",heterozygousDescription:"Carrier: unaffected, slightly elevated phenylalanine",populationFrequency:{CC:.98,CT:.02,TT:1e-4},conditions:["Phenylketonuria (homozygous)","PKU carrier"],recommendations:["Genetic counseling","Partner testing","All newborns screened at birth"],references:["PMID:25087612"]},rs113993960:{rsid:"rs113993960",gene:"CFTR",chromosome:"7",position:117559592,categories:["carrier"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"CFTR — Cystic Fibrosis (F508del proxy)",riskDescription:"CF-associated variant",normalDescription:"Normal CFTR function",heterozygousDescription:"Potential CF carrier",populationFrequency:{CC:.96,CT:.038,TT:.002},conditions:["Cystic fibrosis"],recommendations:["Genetic counseling","Sweat chloride test if symptomatic"],references:["PMID:2475911"]},rs1800553:{rsid:"rs1800553",gene:"GJB2",chromosome:"13",position:20763485,categories:["carrier"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"GJB2 167delT — Hearing Loss",riskDescription:"Carrier of common hearing loss mutation (Ashkenazi Jewish population)",normalDescription:"Normal GJB2/connexin-26",heterozygousDescription:"Carrier: normal hearing",populationFrequency:{CC:.97,CT:.03,TT:3e-4},conditions:["Non-syndromic hearing loss"],recommendations:["Genetic counseling for carriers","Partner testing"],references:["PMID:9771706"]},rs1800548:{rsid:"rs1800548",gene:"SERPINA1",chromosome:"14",position:94847262,categories:["carrier","health"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"SERPINA1 — Alpha-1 Antitrypsin Deficiency",riskDescription:"Z allele carrier: risk of lung and liver disease, especially with smoking",normalDescription:"Normal alpha-1 antitrypsin levels",heterozygousDescription:"MZ carrier: mildly reduced AAT, increased risk if smoking",populationFrequency:{CC:.95,CT:.048,TT:.002},conditions:["Alpha-1 antitrypsin deficiency","COPD","Liver cirrhosis"],recommendations:["Never smoke","AAT level testing","Avoid occupational dust/fume exposure"],references:["PMID:12576314"]},rs74315329:{rsid:"rs74315329",gene:"MUTYH",chromosome:"1",position:45798475,categories:["carrier","health"],significance:"pathogenic",riskAllele:"T",normalAllele:"C",trait:"MUTYH Y179C — Colorectal Cancer",riskDescription:"Biallelic MUTYH mutations: MUTYH-associated polyposis (MAP), high colorectal cancer risk",normalDescription:"Normal MUTYH DNA repair",heterozygousDescription:"Carrier: mildly increased colorectal cancer risk (~1.5x)",populationFrequency:{CC:.98,CT:.019,TT:.001},conditions:["MUTYH-associated polyposis","Colorectal cancer risk"],recommendations:["Enhanced colorectal screening","Colonoscopy starting at 25-30 if biallelic"],references:["PMID:12606733"]}};function c(e){return t[e]||null}function m(e){const i=e.toLowerCase();return Object.values(t).filter(r=>r.rsid.toLowerCase().includes(i)||r.gene.toLowerCase().includes(i)||r.trait.toLowerCase().includes(i))}function d(){const e=new Set;return Object.values(t).forEach(i=>i.categories.forEach(r=>e.add(r))),[...e]}function p(){return Object.values(t)}function g(e){const i=[];for(const[r,n]of Object.entries(t)){const o=e.get(r);if(o){const a=o.genotype||o.allele1+o.allele2,s=l(n,a);i.push({...n,userGenotype:a,userAllele1:o.allele1,userAllele2:o.allele2,riskLevel:s,riskPercent:s==="high"?85:s==="moderate"?55:s==="low"?20:10})}}return i}function l(e,i){const n=i.split("").filter(o=>o===e.riskAllele).length;return n===2?"high":n===1?"moderate":"low"}export{p as a,d as g,c as l,g as m,m as s};
